Blood cancer patients continue experimental drug in long-term safety trial
NCT ID NCT05223920
Summary
This study followed patients with blood cancers called myeloproliferative neoplasms who had already been taking the experimental drug bomedemstat in earlier trials. The goal was to check the long-term safety and effectiveness of continuing this daily oral medication. Researchers monitored side effects and whether the drug continued to help control disease symptoms like enlarged spleen and high platelet counts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera SS. Antonio
Alessandria, 15121, Italy
-
Azienda Ospedaliero Universitaria di Bologna
Pavia, 27100, Italy
-
Azienda Ospedaliero-Universitaria Careggi - S.O.D. Ematologia (CRIMM)
Florence, 50134, Italy
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
Gold Coast Hospital and Health Service
Southport, Queensland, 4215, Australia
-
Guy's and Saint Thomas' NHS Foundation Trus
London, SE1 9RT, United Kingdom
-
Middlemore Clinical Trials
Papatoetoe, Aukland, 2025, New Zealand
-
Ospedale di Circolo-a Fondazione Macchi
Varese, VA, 2100, Italy
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Royal North Shore Hospital
Saint Leonards, New South Wales, 2065, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
UMPC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
Universittsklinikum Essen
Essen, 45147, Germany
-
University College London Hospitals NHS Foundation Trust
London, NW1 12G, United Kingdom
-
University of Miami Leonard M. Miller
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Waitemata District Health Board
Takapuna, Aukland, 0622, New Zealand
Conditions
Explore the condition pages connected to this study.